FTH
Faeth Therapeutics, Inc.Healthcare · $597M market cap
Verdict
We can't put a fair value on FTH right now. It looks like a preferred share, note or other security rather than ordinary common stock. The figures we receive belong to the parent company, so they can't value this security.
Business quality
0 of 5 clear the 10% bar. What are the Big Five?
Follow FTH
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Oct 23, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar). Why purchases matter
Other filings
Questions about FTH
Are insiders buying FTH?
Since Oct 23, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar).
How can I check FTH's value myself?
Use the free Sticker Price calculator, already filled with FTH's numbers. Change the growth, P/E or required return and see what you'd pay. Open the calculator →
Similar stocks · Biotechnology
About Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]
Biotechnology
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of Oct 27, 2026. How the Payback Price works